NCT07528469 The Effects of PeptiStrong and Whey on Muscle Function In Older Adults
| NCT ID | NCT07528469 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Nuritas Ltd |
| Condition | Healthy Ageing |
| Study Type | INTERVENTIONAL |
| Enrollment | 80 participants |
| Start Date | 2026-04-06 |
| Primary Completion | 2026-07-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 80 participants in total. It began in 2026-04-06 with a primary completion date of 2026-07-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Examining the effects of PeptiStrong and protein on muscle function in older adults
Eligibility Criteria
Inclusion Criteria: * Men and women aged 60 to 85 years at the time of enrolment * Community-dwelling (living independently or with minimal assistance) * Able to walk independently (with or without a walking aid) and complete simple physical function tests (such as standing up from a chair and walking short distances) * Willing and able to attend two study visits at the research facility (baseline and end of study) * Willing and able to consume a protein drink containing whey protein (derived from milk) once daily for 30 days * Able to understand the study information and provide written informed consent Exclusion Criteria: * Any known food allergy or intolerance to fava bean protein or milk protein * Diagnosed kidney disease or any medical condition where increased protein intake is contraindicated * Yes to any of the answers on the "Older Adult Functional Assessment Screening Questionnaire" * Individuals with implanted electronic devices * Current or recent (within the past 3 months) participation in another clinical research study involving a nutritional or exercise intervention * Conditions that significantly impair mobility or balance such that safe completion of the physical function tests is not possible
Contact & Investigator
Graeme Close, Professor
PRINCIPAL INVESTIGATOR
Liverpool John Moore University
Frequently Asked Questions
Who can join the NCT07528469 clinical trial?
This trial is open to participants of all sexes, aged 60 Years or older, up to 85 Years, studying Healthy Ageing. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07528469 currently recruiting?
Yes, NCT07528469 is actively recruiting participants. Contact the research team at mohan.niamh@nuritas.com for enrollment information.
Where is the NCT07528469 trial being conducted?
This trial is being conducted at Liverpool, United Kingdom.
Who is sponsoring the NCT07528469 clinical trial?
NCT07528469 is sponsored by Nuritas Ltd. The principal investigator is Graeme Close, Professor at Liverpool John Moore University. The trial plans to enroll 80 participants.